A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

89

A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

Tags:

Previous Article

Monitoring dynamic single-cell events using noninvasive methods

A next-generation HDAC6 inhibitor for ALS treatment

Related Posts

The Wnt–NAD+ axis in cancer, aging, and tissue regeneration

The Wnt–NAD+ axis in cancer, aging, and tissue regenera...

485

Oligodendrocyte mechanotransduction channel TMEM63A regulates myelin sheath geometry

Oligodendrocyte mechanotransduction channel TMEM63A reg...

86

Protein-based molecular imprinting: gelatin nanotraps for interleukin-6 sequestration in inflammation cell models

Protein-based molecular imprinting: gelatin nanotraps f...

153